Sotera Health vs Bio-Techne
Sotera Health and Bio-Techne are similar in size: $1.16bn and $1.22bn of revenue in their latest fiscal years. Sotera Health grew faster (5.7% against -0.4%). Bio-Techne kept more of each dollar of sales as profit: a net margin of 15.0% against 6.7%. Bio-Techne carries less debt relative to equity (9.5% against 358.0%).
| Latest fiscal year | Sotera HealthSHC, 2025 | Bio-TechneTECH, 2026 |
|---|---|---|
| Revenue | $1.16bn | $1.22bn |
| Revenue growth | 5.7% | -0.4% |
| Net income | $77.9m | $182m |
| Operating margin | — | 20.7% |
| Net margin | 6.7% | 15.0% |
| Return on equity | 15.4% | 9.0% |
| Free cash flow | $149m | $263m |
| Cash | $345m | $265m |
| Total debt | $2.17bn | $200m |
| Debt to equity | 358.0% | 9.5% |
| Dividend per share | — | $0.32 |
| Dividend yield | — | 0.4% |
| Share buybacks | — | $41.7m |
| Employees | 3,000 | 3,000 |
| Market value | $5.11bn | $11.34bn |
| Price vs our value range | — | Above our value range |
| Moat score | 72 (Strong) | 76 (Strong) |
| Insider trades, 12 months | 0 buys, 18 sales | 0 buys, 2 sales |